The next board meeting for Ligand Pharma Inc (Class B) is on 08 May 2026 for the purpose of Ligand Pharmaceuticals Inc First Quarter Earnings Results for 2026See details
Ligand Pharma Inc (Class B) - LGND - stock price prediction, stock price target, analyst ratings from 9 analysts
Ligand Pharma Inc (Class B) has a share price target of US$ 269, revenue growth forecast of 7.8%, and profit growth estimate of -3.7% for FY26, based on top 9 analyst calls.